Targeting the cGAS-STING pathway as an inflammatory crossroad in coronavirus disease 2019 (COVID-19).

Elahi, Reza; Hozhabri, Salar; Moradi, Amirhosein; Siahmansouri, Amir; Jahani Maleki, Armin; Esmaeilzadeh, Abdolreza

Elahi, Reza; Hozhabri, Salar; Moradi, Amirhosein; Siahmansouri, Amir; Jahani Maleki, Armin; Esmaeilzadeh, Abdolreza.

Afiliación

Elahi R; School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Hozhabri S; School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Moradi A; School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Siahmansouri A; School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Jahani Maleki A; School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Esmaeilzadeh A; Department of Immunology, Zanjan University of Medical Sciences, Zanjan, Iran.

Immunopharmacol Immunotoxicol ; 45(6): 639-649, 2023 Dec.

Article en En | MEDLINE | ID: mdl-37335770

Asunto(s)

COVID-19; Humanos; SARS-CoV-2/metabolismo; Síndrome de Liberación de Citoquinas; Citocinas/metabolismo; Nucleotidiltransferasas/metabolismo

Palabras clave

STING; cGAS; coronavirus disease 2019 (COVID-19); immune response; inflammation; interferon

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Immunopharmacol Immunotoxicol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA / TOXICOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google